Benzinga | Jun 10, 2021 06:47AM EDT

B of A Securities Downgrades Clover Health Investments to Underperform, Announces $10 Price Target

B of A Securities analyst Kevin Fischbeck downgrades Clover Health Investments (NASDAQ:CLOV) from Neutral to Underperform and announces $10 price target.